Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome

Alexandra E. Butler, Shahina Hayat, Soha R. Dargham, Joel A. Malek, Silvana A. Abdulla, Yasmin A. Mohamoud, Karsten Suhre, Thozhukat Sathyapalan, Stephen L. Atkin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Long noncoding RNAs (lncRNAs) are RNA transcripts over 200 nucleotides long that are not translated into protein; however, there is increasing evidence of their regulatory functions. To date, there are few studies measuring lncRNA in control women or women with polycystic ovary syndrome (PCOS). Objective: To determine lncRNA differences between PCOS and control women. Design: Cross sectional study. Patients: Twenty four anovulatory women with all three diagnostic features of PCOS compared to 24 control women in the follicular phase of their menstrual cycle from a PCOS biobank. Results: Women with PCOS were age and weight matched compared to the control women but were significantly insulin resistant and hyperandrogenemic (P <.01). Eight lncRNA (P <.05) were detected that differed between PCOS and control women, but only MIRLET7BHG correlated with body mass index (r =.66, P <.05). No lncRNA correlated with antimullerian hormone (AMH) levels, insulin resistance (HOMA-IR) or the free androgen index (FAI). Ingenuity pathway assessment (IPA) did not identify any functional pathways for the lncRNAs. Conclusion: LncRNAs differ between anovulatory PCOS and control women in the follicular phase of the menstrual cycle. It is unclear if this is due to inherent differences between PCOS and control women or due to changes in lncRNA that are menstrual cycle dependent. However, their IPA did not identify linked pathways, likely because few functions are as yet assigned to these lncRNAs.

Original languageEnglish
JournalClinical Endocrinology
DOIs
Publication statusAccepted/In press - 1 Jan 2019

Fingerprint

Long Noncoding RNA
Polycystic Ovary Syndrome
Follicular Phase
Anti-Mullerian Hormone
Menstrual Cycle
Androgens
Insulin Resistance
Body Mass Index
Nucleotides
Cross-Sectional Studies

Keywords

  • long noncoding RNA
  • polycystic ovarian syndrome

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{eb1e8bc01b2446d080ce68633723dcb4,
title = "Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome",
abstract = "Long noncoding RNAs (lncRNAs) are RNA transcripts over 200 nucleotides long that are not translated into protein; however, there is increasing evidence of their regulatory functions. To date, there are few studies measuring lncRNA in control women or women with polycystic ovary syndrome (PCOS). Objective: To determine lncRNA differences between PCOS and control women. Design: Cross sectional study. Patients: Twenty four anovulatory women with all three diagnostic features of PCOS compared to 24 control women in the follicular phase of their menstrual cycle from a PCOS biobank. Results: Women with PCOS were age and weight matched compared to the control women but were significantly insulin resistant and hyperandrogenemic (P <.01). Eight lncRNA (P <.05) were detected that differed between PCOS and control women, but only MIRLET7BHG correlated with body mass index (r =.66, P <.05). No lncRNA correlated with antimullerian hormone (AMH) levels, insulin resistance (HOMA-IR) or the free androgen index (FAI). Ingenuity pathway assessment (IPA) did not identify any functional pathways for the lncRNAs. Conclusion: LncRNAs differ between anovulatory PCOS and control women in the follicular phase of the menstrual cycle. It is unclear if this is due to inherent differences between PCOS and control women or due to changes in lncRNA that are menstrual cycle dependent. However, their IPA did not identify linked pathways, likely because few functions are as yet assigned to these lncRNAs.",
keywords = "long noncoding RNA, polycystic ovarian syndrome",
author = "Butler, {Alexandra E.} and Shahina Hayat and Dargham, {Soha R.} and Malek, {Joel A.} and Abdulla, {Silvana A.} and Mohamoud, {Yasmin A.} and Karsten Suhre and Thozhukat Sathyapalan and Atkin, {Stephen L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/cen.14087",
language = "English",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome

AU - Butler, Alexandra E.

AU - Hayat, Shahina

AU - Dargham, Soha R.

AU - Malek, Joel A.

AU - Abdulla, Silvana A.

AU - Mohamoud, Yasmin A.

AU - Suhre, Karsten

AU - Sathyapalan, Thozhukat

AU - Atkin, Stephen L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Long noncoding RNAs (lncRNAs) are RNA transcripts over 200 nucleotides long that are not translated into protein; however, there is increasing evidence of their regulatory functions. To date, there are few studies measuring lncRNA in control women or women with polycystic ovary syndrome (PCOS). Objective: To determine lncRNA differences between PCOS and control women. Design: Cross sectional study. Patients: Twenty four anovulatory women with all three diagnostic features of PCOS compared to 24 control women in the follicular phase of their menstrual cycle from a PCOS biobank. Results: Women with PCOS were age and weight matched compared to the control women but were significantly insulin resistant and hyperandrogenemic (P <.01). Eight lncRNA (P <.05) were detected that differed between PCOS and control women, but only MIRLET7BHG correlated with body mass index (r =.66, P <.05). No lncRNA correlated with antimullerian hormone (AMH) levels, insulin resistance (HOMA-IR) or the free androgen index (FAI). Ingenuity pathway assessment (IPA) did not identify any functional pathways for the lncRNAs. Conclusion: LncRNAs differ between anovulatory PCOS and control women in the follicular phase of the menstrual cycle. It is unclear if this is due to inherent differences between PCOS and control women or due to changes in lncRNA that are menstrual cycle dependent. However, their IPA did not identify linked pathways, likely because few functions are as yet assigned to these lncRNAs.

AB - Long noncoding RNAs (lncRNAs) are RNA transcripts over 200 nucleotides long that are not translated into protein; however, there is increasing evidence of their regulatory functions. To date, there are few studies measuring lncRNA in control women or women with polycystic ovary syndrome (PCOS). Objective: To determine lncRNA differences between PCOS and control women. Design: Cross sectional study. Patients: Twenty four anovulatory women with all three diagnostic features of PCOS compared to 24 control women in the follicular phase of their menstrual cycle from a PCOS biobank. Results: Women with PCOS were age and weight matched compared to the control women but were significantly insulin resistant and hyperandrogenemic (P <.01). Eight lncRNA (P <.05) were detected that differed between PCOS and control women, but only MIRLET7BHG correlated with body mass index (r =.66, P <.05). No lncRNA correlated with antimullerian hormone (AMH) levels, insulin resistance (HOMA-IR) or the free androgen index (FAI). Ingenuity pathway assessment (IPA) did not identify any functional pathways for the lncRNAs. Conclusion: LncRNAs differ between anovulatory PCOS and control women in the follicular phase of the menstrual cycle. It is unclear if this is due to inherent differences between PCOS and control women or due to changes in lncRNA that are menstrual cycle dependent. However, their IPA did not identify linked pathways, likely because few functions are as yet assigned to these lncRNAs.

KW - long noncoding RNA

KW - polycystic ovarian syndrome

UR - http://www.scopus.com/inward/record.url?scp=85073962087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073962087&partnerID=8YFLogxK

U2 - 10.1111/cen.14087

DO - 10.1111/cen.14087

M3 - Article

C2 - 31482638

AN - SCOPUS:85073962087

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

ER -